Related Experiment Video
Updated: Jun 8, 2025

09:41
Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
2.7K
PPARs: modulating lipotoxicity and thus inhibiting fibrosis
Wen-Rui Li1, Chunping Zhang2, Jing Wang3
1The Second Clinical Medical College, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China.
Summary
Peroxisome proliferator-activated receptors (PPARs) link lipid metabolism and fibrosis. This review explores how PPARs regulate fibrosis via lipid metabolism, offering insights for treating these interconnected conditions.
Area of Science:
- Molecular biology
- Metabolic research
- Fibrosis research
Background:
- Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors crucial for lipid metabolism.
- Emerging research highlights a connection between PPARs and fibrosis.
- Lipid metabolism disorders and fibrosis are known to be interrelated.
Purpose of the Study:
- To review the molecular mechanisms of PPARs in regulating fibrosis through lipid metabolism.
- To examine the direct role of PPARγ in fibrosis.
- To identify current challenges and future research directions for PPARs in treating lipid disorders and fibrosis.
Main Methods:
- Literature review and synthesis of existing research on PPARs, lipid metabolism, and fibrosis.
- Analysis of molecular pathways linking PPARs to fibrotic processes.
- Identification of research gaps and contradictions.
Main Results:
- PPARs regulate fibrosis through modulation of lipid metabolism pathways.
- PPARγ has a direct role in fibrotic processes.
- Interplay between lipid metabolism and fibrosis is a key mechanism influenced by PPARs.
Conclusions:
- PPARs represent a potential therapeutic target for co-treating lipid metabolism disorders and fibrosis.
- Further research is needed to elucidate the complex interactions and resolve existing enigmas.
- Understanding these mechanisms can pave the way for novel therapeutic strategies.

